Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis.
[Anesthetic Management of Three Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome.
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
Current and Emerging Therapies for Multiple Sclerosis.
C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis.
The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis.
Neuromyelitis optica.
Epistatic effects on the phenotype of multiple sclerosis.
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate.
"Nine" syndrome: A new neuro-ophthalmologic syndrome: Report of two cases.
Hyperhomocysteinemia and neurologic disorders: a review.
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.
Prognostic indicators of secondary progression in a paediatric-onset multiple sclerosis cohort in Kuwait.
Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis.
Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection.
Vitamin D and multiple sclerosis-from epidemiology to prevention.
Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
Antibody-based profiling of cerebrospinal fluid within multiple sclerosis.
Pages
« first
‹ previous
…
642
643
644
645
646
647
648
649
650
…
next ›
last »